Kimble T F Matos相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19

抗 CD3 mAb（Foralumab）鼻腔给药可下调 COVID-19 患者 T 细胞中的 NKG7 表达，并增加 TGFB1 和 GIMAP7 表达

期刊:Proceedings of the National Academy of Sciences of the United States of America

doi:10.1073/pnas.2220272120

Thais G Moreira, Christian D Gauthier, Liam Murphy, Toby B Lanser, Anu Paul, Kimble T F Matos, Davide Mangani, Saef Izzy, Rafael M Rezende, Brian C Healy, Clare M Baecher-Allan, Tanuja Chitnis, Vijay Kuchroo, Howard L Weiner

发表日期：2023

文献求助收藏

Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study

勘误表：抗 CD3 单克隆抗体 (Foralumab) 鼻腔给药可减少轻度至中度 COVID-19 患者的肺部炎症和血液炎症生物标志物：一项试点研究

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2021.815812

Thais G Moreira, Kimble T F Matos, Giovana S De Paula, Thais M M Santana, Raquel G Da Mata, Fernando C Pansera, Andre S Cortina, Marcelle G Spinola, Clare M Baecher-Allan, Gerson D Keppeke, Jules Jacob, Vaseem Palejwala, Karen Chen, Saef Izzy, Brian C Healey, Rafael M Rezende, Rogerio A Dedivitis, K

Immunology/Inflammation

发表日期：2022

文献求助收藏

Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study

抗 CD3 单克隆抗体 (Foralumab) 鼻腔给药可减少轻度至中度 COVID-19 患者的肺部炎症和血液炎症生物标志物：一项初步研究

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2021.709861

Thais G Moreira, Kimble T F Matos, Giovana S De Paula, Thais M M Santana, Raquel G Da Mata, Fernando C Pansera, Andre S Cortina, Marcelle G Spinola, Clare M Baecher-Allan, Gerson D Keppeke, Jules Jacob, Vaseem Palejwala, Karen Chen, Saef Izzy, Brian C Healey, Rafael M Rezende, Rogerio A Dedivitis, K

发表日期：2021

文献求助收藏